Clinical Trial Update: Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hippocampal-sparing during whole-brain radiation therapy for brain metastases; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Cognitive/Functional Effects, Metastatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-09-27